Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.19.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The Company presents restricted cash with cash and cash equivalents in the Consolidated Statements of Cash Flows.

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Consolidated Balance Sheets to the total of the amounts in the Consolidated Statements of Cash Flows as of September 30, 2019, December 31, 2018, September 30, 2018 and December 31, 2017:

 

    September 30,
2019		     December 31,
2018		     September 30,
2018		     December 31,
2017		  
Cash and cash equivalents   $ 32,665     $ 12,447     $ 6,632     $ 7,307  
                                 
Restricted cash included in current/long term assets     586       561       636       691  
                                 
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 33,251     $ 13,008     $ 7,268     $ 7,998  

Schedule of Antidilutive Securities

The following table provides the number of shares of common stock issuable upon the exercise of stock options, warrants and conversion of preferred stock, which have been excluded from the diluted loss per share calculation as the inclusion would be anti-dilutive for the three and nine months ended September 30, 2019 and 2018:

 

    As of September 30,  
    2019     2018  
Stock options     16,859       11,455  
Convertible preferred stock and accrued dividends upon conversion     9,240       28,685  
Warrants     5,799       5,802  
Total     31,898       45,942